Clonal architecture inferred from routine NGS data predicts outcome and response to JAK-inhibitors in myelofibrosis
Authors
- Luca Guarnera (ORCID: https://orcid.org/0000-0001-8293-0663)
- Paola Guglielmelli (ORCID: https://orcid.org/0000-0003-1809-284X)
- Giulio Capecchi
- Alessio Enderti
- Luca Maurillo (ORCID: https://orcid.org/0000-0001-7297-4988)
- Christian Basile (ORCID: https://orcid.org/0000-0002-4680-3058)
- Giacomo Coltro
- Alessandro Maria Vannucchi (ORCID: https://orcid.org/0000-0001-5755-0730)
- C. Ghetti (ORCID: https://orcid.org/0000-0002-1976-4540)
- Emilia Scalzulli
- Giuseppe Gaetano Loscocco (ORCID: https://orcid.org/0000-0002-6241-1206)
- Maria Teresa Voso (ORCID: https://orcid.org/0000-0002-6164-4761)
- Fiorenza Vanderwert
- Valentina Boldrini (ORCID: https://orcid.org/0000-0001-5463-4736)
- Massimo Breccia (ORCID: https://orcid.org/0000-0003-1163-6162)
- Lucrezia Morrone
Institutions
- University of Rome Tor Vergata (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Blood
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1182/blood-2025-3753
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00